Mineralocorticoid receptor null mice: Informing cell-type-specific roles

Journal of Endocrinology

Volumn 234, Issue 1, 2017, Pages T83-T92

  Cole, Timothy J ^a,b   Young, Morag J ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Aldosterone; Cortisol; Mineralocorticoid receptors; Null mice

Indexed keywords

ALDOSTERONE; CORTICOSTEROID; CRE RECOMBINASE; MESSENGER RNA; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; RENIN; SMALL INTERFERING RNA;

ALDOSTERONE BLOOD LEVEL; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELLS BY BODY ANATOMY; EPITHELIUM CELL; GENE DELETION; GENE MUTATION; GENE TARGETING; GENOMICS; HYPERKALEMIA; IN VIVO STUDY; INTRACELLULAR SPACE; LOXP SITE; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; SALT WASTING; SIGNAL TRANSDUCTION; STRESS; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION; KIDNEY; MICE; MICE, KNOCKOUT; RECEPTORS, MINERALOCORTICOID;

EID: 85023206564     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-17-0155     Document Type: Review

References (64)

1. Amador CA, Bertocchio JP, Andre-Gregoire G, Placier S, Duong Van Huyen JP, El Moghrabi S, Berger S, Warnock DG, Chatziantoniou C, Jaffe IZ, et al. 2016. Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration. Kidney International 89:354-362. (doi:10.1038/ki.2015.312)
2. Amazit L, Le Billan F, Kolkhof P, Lamribet K, Viengchareun S, Fay MR, Khan JA, Hillisch A, Lombes M, Rafestin-Oblin ME, et al. 2015. Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1. Journal of Biological Chemistry 290:21876-21889. (doi:10.1074/jbc.M115.657957)
3. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE & Evans RM. 1987. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275. (doi:10.1126/science.3037703)
4. Baker ME. 2004. Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors. Molecular and Cellular Endocrinology 215:55-62. (doi:10.1016/j.mce.2003.11.007)
5. Beggah AT, Escoubet B, Puttini S, Cailmail S, Delage V, Ouvrard-Pascaud A, Bocchi B, Peuchmaur M, Delcayre C, Farman N, et al. 2002. Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. PNAS 99:7160-7165. (doi:10.1073/pnas.102673599)
6. Berger S, Bleich M, Schmid W, Cole TJ, Peters J, Watanabe H, Kriz W, Warth R, Greger R & Schutz G. 1998. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. PNAS 95:9424-9429. (doi:10.1073/pnas.95.16.9424)
7. Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, Chepkova AN, Welzl H, Haas HL, Lipp HP, et al. 2006. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. PNAS 103:195-200. (doi:10.1073/pnas.0503878102)
8. Bienvenu LA, Morgan J, Rickard AJ, Tesch GH, Cranston GA, Fletcher EK, Delbridge LM & Young MJ. 2012. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis. Endocrinology 153:3416-3425. (doi:10.1210/en.2011-2098)
9. Bienvenu LA, Reichelt ME, Morgan J, Fletcher EK, Bell JR, Rickard AJ, Delbridge LM & Young MJ. 2015. Cardiomyocyte mineralocorticoid receptor activation impairs acute cardiac functional recovery after ischemic insult. Hypertension 66:970-977. (doi:10.1161/HYPERTENSIONAHA.115.05981)
10. Bleich M, Warth R, Schmidt-Hieber M, Schulz-Baldes A, Hasselblatt P, Fisch D, Berger S, Kunzelmann K, Kriz W, Schutz G, et al. 1999. Rescue of the mineralocorticoid receptor knock-out mouse. Pflügers Archiv 438:245-254. (doi:10.1007/s004240050906)
11. Boix J, Sevilla LM, Saez Z, Carceller E & Perez P. 2016. Epidermal mineralocorticoid receptor plays beneficial and adverse effects in skin and mediates glucocorticoid responses. Journal of Investigative Dermatology 136:2417-2426. (doi:10.1016/j.jid.2016.07.018)
12. Brinks V, Berger S, Gass P, de Kloet ER & Oitzl MS. 2009. Mineralocorticoid receptors in control of emotional arousal and fear memory. Hormones and Behavior 56:232-238. (doi:10.1016/j.yhbeh.2009.05.003)
13. Canonica J, Sergi C, Maillard M, Klusonova P, Odermatt A, Koesters R, Loffing-Cueni D, Loffing J, Rossier B, Frateschi S, et al. 2016. Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype. Pflügers Archiv 468:895-908. (doi:10.1007/s00424-015-1785-2)
14. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K & Schutz G. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes and Development 9:1608-1621. (doi:10.1101/gad.9.13.1608)
15. Cole TJ, Terella L, Morgan J, Alexiadis M, Yao YZ, Enriori P, Young MJ & Fuller PJ. 2015. Aldosterone-mediated renal sodium transport requires intact mineralocorticoid receptor DNA-binding in the mouse. Endocrinology 156:2958-2968. (doi:10.1210/en.2015-1008)
16. de Kloet ER, Joels M & Holsboer F. 2005. Stress and the brain: from adaptation to disease. Nature Reviews Neuroscience 6:463-475. (doi:10.1038/nrn1683)
17. El Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, Louvard D, Chambon P, Metzger D & Robine S. 2004. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39:186-193. (doi:10.1002/gene.20042)
18. Fraccarollo D, Berger S, Galuppo P, Kneitz S, Hein L, Schutz G, Frantz S, Ertl G & Bauersachs J. 2011. Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123:400-408. (doi:10.1161/CIRCULATIONAHA.110.983023)
19. Friedel RH, Wurst W, Wefers B & Kuhn R. 2011. Generating conditional knockout mice. Methods in Molecular Biology 693:205-231. (doi:10.1007/978-1-60761-974-1_12)
20. Frieler RA, Meng H, Duan SZ, Berger S, Schutz G, He Y, Xi G, Wang MM & Mortensen RM. 2011. Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia. Stroke 42:179-185. (doi:10.1161/STROKEAHA.110.598441)
21. Frieler RA, Ray JJ, Meng H, Ramnarayanan SP, Usher MG, Su EJ, Berger S, Pinsky DJ, Lawrence DA, Wang MM, et al. 2012. Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex. Journal of the American Heart Association 1:e002584. (doi:10.1161/jaha.112.002584)
22. Funder JW. 2010. Minireview: aldosterone and mineralocorticoid receptors: past, present, and future. Endocrinology 151:5098-5102. (doi:10.1210/en.2010-0465)
23. Funder JW. 2017. Apparent mineralocorticoid excess. Journal of Steroid Biochemistry and Molecular Biology 165:151-153. (doi:10.1016/j. jsbmb.2016.03.010)
24. Gass P, Kretz O, Wolfer DP, Berger S, Tronche F, Reichardt HM, Kellendonk C, Lipp HP, Schmid W & Schutz G. 2000. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Reports 1:447-451. (doi:10.1093/embo-reports/kvd088)
25. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB & Lifton RP. 2000. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119-123. (doi:10.1126/science.289.5476.119)
26. Gomez-Sanchez E & Gomez-Sanchez CE. 2014. The multifaceted mineralocorticoid receptor. Comprehensive Physiology 4:965-994. (doi:10.1002/cphy.c130044)
27. Hoppmann J, Perwitz N, Meier B, Fasshauer M, Hadaschik D, Lehnert H & Klein J. 2010. The balance between gluco-and mineralo-corticoid action critically determines inflammatory adipocyte responses. Journal of Endocrinology 204:153-164. (doi:10.1677/JOE-09-0292)
28. Hubert C, Gasc JM, Berger S, Schutz G & Corvol P. 1999. Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice. Molecular Endocrinology 13:297-306. (doi:10.1210/mend.13.2.0241)
29. Jia G, Habibi J, DeMarco VG, Martinez-Lemus LA, Ma L, Whaley-Connell AT, Aroor AR, Domeier TL, Zhu Y, Meininger GA, et al. 2015. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension 66:1159-1167. (doi:10.1161/HYPERTENSIONAHA.115.06015)
30. Jia G, Habibi J, Aroor AR, Martinez-Lemus LA, DeMarco VG, Ramirez-Perez FI, Sun Z, Hayden MR, Meininger GA, Mueller KB, et al. 2016. Endothelial mineralocorticoid receptor mediates diet-induced aortic stiffness in females. Circulation Research 118:935-943. (doi:10.1161/CIRCRESAHA.115.308269)
31. Karst H, Berger S, Turiault M, Tronche F, Schutz G & Joels M. 2005. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. PNAS 102:19204-19207. (doi:10.1073/pnas.0507572102)
32. Kolber BJ, Wieczorek L & Muglia LJ. 2008. Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function. Stress 11:321-338. (doi:10.1080/10253890701821081)
33. Lai M, Horsburgh K, Bae SE, Carter RN, Stenvers DJ, Fowler JH, Yau JL, Gomez-Sanchez CE, Holmes MC, Kenyon CJ, et al. 2007. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. European Journal of Neuroscience 25:1832-1842. (doi:10.1111/j.1460-9568.2007.05427.x)
34. Lim HY, van den Brandt J, Fassnacht M, Allolio B, Herold MJ & Reichardt HM. 2008. Silencing of the mineralocorticoid receptor by ribonucleic acid interference in transgenic rats disrupts endocrine homeostasis. Molecular Endocrinology 22:1304-1311. (doi:10.1210/me.2007-0417)
35. Lother A, Berger S, Gilsbach R, Rosner S, Ecke A, Barreto F, Bauersachs J, Schutz G & Hein L. 2011. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function. Hypertension 57:746-754. (doi:10.1161/HYPERTENSIONAHA.110.163287)
36. Martinerie L, Viengchareun S, Delezoide AL, Jaubert F, Sinico M, Prevot S, Boileau P, Meduri G & Lombes M. 2009. Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates. Endocrinology 150:4414-4424. (doi:10.1210/en.2008-1498)
37. Martinerie L, Viengchareun S, Meduri G, Kim HS, Luther JM & Lombes M. 2011. Aldosterone postnatally, but not at birth, is required for optimal induction of renal mineralocorticoid receptor expression and sodium reabsorption. Endocrinology 152:2483-2491. (doi:10.1210/en.2010-1460)
38. McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, et al. 2012. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nature Medicine 18:1429-1433. (doi:10.1038/nm.2891)
39. McKenna NJ, Evans RM & O'Malley BW. 2014. Nuclear receptor signaling: a home for nuclear receptor and coregulator signaling research. Nuclear Receptor Signaling 12:e006
40. Montes-Cobos E, Li X, Fischer HJ, Sasse A, Kugler S, Didie M, Toischer K, Fassnacht M, Dressel R & Reichardt HM. 2015. Inducible knock-down of the mineralocorticoid receptor in mice disturbs regulation of the renin-angiotensin-aldosterone system and attenuates heart failure induced by pressure overload. PLoS ONE 10:e0143954. (doi:10.1371/journal.pone.0143954)
41. Mueller KB, Bender SB, Hong K, Yang Y, Aronovitz M, Jaisser F, Hill MA & Jaffe IZ. 2015. Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure. Hypertension 66:988-997. (doi:10.1161/HYPERTENSIONAHA.115.06172)
42. Obradovic D, Tirard M, Nemethy Z, Hirsch O, Gronemeyer H & Almeida OF. 2004. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors? Molecular Pharmacology 65 761-769. (doi:10.1124/mol.65.3.761)
43. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J & Wittes J. 1999. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine 341:709-717. (doi:10.1056/NEJM199909023411001)
44. Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, et al. 2001. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone post-AMI heart failure efficacy and survival study. Cardiovascular Drugs and Therapy 15:79-87. (doi:10.1023/A:1011119003788)
45. Pruthi D, McCurley A, Aronovitz M, Galayda C, Karumanchi SA & Jaffe IZ. 2014. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Arteriosclerosis, Thrombosis, and Vascular Biology 34:355-364. (doi:10.1161/ATVBAHA.113.302854)
46. Rafestin-Oblin ME, Souque A, Bocchi B, Pinon G, Fagart J & Vandewalle A. 2003. The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology 144:528-533. (doi:10.1210/en.2002-220708)
47. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA & Zhang F. 2013. Genome engineering using the CRISPR-Cas9 system. Nature Protocols 8:2281-2308. (doi:10.1038/nprot.2013.143)
48. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, et al. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541. (doi:10.1016/S0092-8674(00)81183-6)
49. Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ & Young MJ. 2009. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 54:537-543. (doi:10.1161/HYPERTENSIONAHA.109.131110)
50. Rickard AJ, Morgan J, Bienvenu LA, Fletcher EK, Cranston GA, Shen JZ, Reichelt ME, Delbridge LM & Young MJ. 2012. Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis. Hypertension 60:1443-1450. (doi:10.1161/HYPERTENSIONAHA.112.203158)
51. Rickard AJ, Morgan J, Chrissobolis S, Miller AA, Sobey CG & Young MJ. 2014. Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension 63:1033-1040. (doi:10.1161/HYPERTENSIONAHA.113.01803)
52. Rogerson FM, Yao YZ, Young MJ & Fuller PJ. 2014. Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator. FASEB Journal 28:4200-4210. (doi:10.1096/fj.13-242479)
53. Ronzaud C, Loffing J, Bleich M, Gretz N, Grone HJ, Schutz G & Berger S. 2007. Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor. Journal of the American Society of Nephrology 18:1679-1687. (doi:10.1681/ASN.2006090975)
54. Rozeboom AM, Akil H & Seasholtz AF. 2007. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. PNAS 104:4688-4693. (doi:10.1073/pnas.0606067104)
55. Schafer N, Lohmann C, Winnik S, van Tits LJ, Miranda MX, Vergopoulos A, Ruschitzka F, Nussberger J, Berger S, Luscher TF, et al. 2013. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. European Heart Journal 34:3515-3524. (doi:10.1093/eurheartj/eht095)
56. Shen JZ, Morgan J, Tesch GH, Rickard AJ, Chrissobolis S, Drummond GR, Fuller PJ & Young MJ. 2016. Cardiac tissue injury and remodeling is dependent upon MR regulation of activation pathways in cardiac tissue macrophages. Endocrinology 157:3213-3223. (doi:10.1210/en.2016-1040)
57. Sun Z, Bello-Roufai M & Wang X. 2008. RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension. American Journal of Physiology: Heart and Circulatory Physiology 294:H1880-H1887. (doi:10.1152/ajpcell.00129.2008)
58. Sun JY, Li C, Shen ZX, Zhang WC, Ai TJ, Du LJ, Zhang YY, Yao GF, Liu Y, Sun S, et al. 2016. Mineralocorticoid receptor deficiency in macrophages inhibits neointimal hyperplasia and suppresses macrophage inflammation through SGK1-AP1/NF-kappaB pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 36:874-885. (doi:10.1161/ATVBAHA.115.307031)
59. Terker AS, Yarbrough B, Ferdaus MZ, Lazelle RA, Erspamer KJ, Meermeier NP, Park HJ, McCormick JA, Yang CL & Ellison DH. 2016. Direct and indirect mineralocorticoid effects determine distal salt transport. Journal of the American Society of Nephrology 27:2436-2445. (doi:10.1681/ASN.2015070815)
60. Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schutz G, Lumeng CN & Mortensen RM. 2010. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. Journal of Clinical Investigation 120:3350-3364. (doi:10.1172/JCI41080)
61. Wintermantel TM, Berger S, Greiner EF & Schutz G. 2005. Evaluation of steroid receptor function by gene targeting in mice. Journal of Steroid Biochemistry and Molecular Biology 93:107-112. (doi:10.1016/j. jsbmb.2004.12.033)
62. Yang J & Young MJ. 2016. Mineralocorticoid receptor antagonistspharmacodynamics and pharmacokinetic differences. Current Opinion in Pharmacology 27:78-85. (doi:10.1016/j.coph.2016.02.005)
63. Young MJ & Funder JW. 1996. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis. American Journal of Physiology 271:E883-E888
64. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B & Group E-HS. 2011. Eplerenone in patients with systolic heart failure and mild symptoms. New England Journal of Medicine 364:11-21. (doi:10.1056/NEJMoa1009492)